Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved multiple immune-related conditions in one patient.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Midazolam's antiseizure effects are mainly due to synaptic GABA-A receptors, not neurosteroids or extrasynaptic receptors.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Cepharanthine shows promise as a COVID-19 treatment.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

LDE225 is a promising skin-applied treatment for basal cell carcinoma with good skin penetration and effectiveness.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

Baicalin may help treat severe drug-induced skin reactions.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Divalproex sodium can unexpectedly cause agitation and hyperactivity in some patients.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Clascoterone may be an effective topical treatment for hair loss.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

Finasteride may help reduce impulsivity caused by pramipexole.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.